These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6696498)

  • 21. Partial splenectomy in homozygous beta thalassaemia.
    de Montalembert M; Girot R; Revillon Y; Jan D; Adjrad L; Ardjoun FZ; Belhani M; Najean Y
    Arch Dis Child; 1990 Mar; 65(3):304-7. PubMed ID: 2334210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of splenectomy in the treatment of Cooley's disease].
    Rocca E; Placida G; Alberti A
    Minerva Chir; 1986 Mar; 41(5-6):317-23. PubMed ID: 3725056
    [No Abstract]   [Full Text] [Related]  

  • 23. Progressive liver disease in haemophilia: an understated problem?
    Hay CR; Preston FE; Triger DR; Underwood JC
    Lancet; 1985 Jun; 1(8444):1495-8. PubMed ID: 2861420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
    Di Marco V; Capra M; Gagliardotto F; Borsellino Z; Cabibi D; Barbaria F; Ferraro D; Cuccia L; Ruffo GB; Bronte F; Di Stefano R; Almasio PL; Craxì A
    Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome.
    Mattsson L; Weiland O; Glaumann H
    Liver; 1988 Jun; 8(3):184-8. PubMed ID: 3134588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histopathological and ultrastructural aspects of the spleen in Cooley's disease under various conditions of transfusion and therapeutic treatment].
    Corda R; Biddau P; Ruggiu MR; Zucca G; Onnis C
    Arch De Vecchi Anat Patol; 1976 Dec; 61(3):431-54. PubMed ID: 1030613
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-thalassaemia--the Johannesburg experience.
    Poole JE; Cohn RJ; Roode H; Spector I
    S Afr Med J; 1989 Apr; 75(8):367-70. PubMed ID: 2652340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total management of thalassaemia major.
    Modell B
    Arch Dis Child; 1977 Jun; 52(6):489-500. PubMed ID: 879834
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme.
    Rebulla P; Modell B
    Lancet; 1991 Feb; 337(8736):277-80. PubMed ID: 1671122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.
    Papaevangelou G; Frösner G; Economidou J; Parcha S; Roumeliotou A
    Br Med J; 1978 Mar; 1(6114):689-91. PubMed ID: 630296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical aspects of thalassemia (or microcythemia)].
    Bianco I
    Minerva Med; 1981 Nov; 72(43):2865-82. PubMed ID: 7301167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemochromatosis in a case of thalassaemia haemoglobin E disease presenting with cirrhosis of liver.
    Mitra R; Sarkar S; Ganguli S; De BK
    J Indian Med Assoc; 1996 Jan; 94(1):29-30. PubMed ID: 8776041
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disproportionate lymphoid cell subsets in thalassaemia major: the relative contributions of transfusion and splenectomy.
    Grady RW; Akbar AN; Giardina PJ; Hilgartner MW; de Sousa M
    Br J Haematol; 1985 Apr; 59(4):713-24. PubMed ID: 3872679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of Cooley's anemia.
    Nathan DG
    Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
    [No Abstract]   [Full Text] [Related]  

  • 36. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Thursz M
    Gut; 2007 May; 56(5):613-4. PubMed ID: 17440181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.
    De Virgiliis S; Fiorelli G; Fargion S; Cornacchia G; Sanna G; Cossu P; Murgia V; Cao A
    J Clin Pathol; 1980 Oct; 33(10):949-53. PubMed ID: 7430360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behaviour of myeloid precursors in homozygous beta thalassaemia.
    Gabutti V; Miniero R; Piga A; Incarbone E; Sacchetti L; Balegno G
    Br J Haematol; 1980 Aug; 45(4):599-605. PubMed ID: 7426439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic and splenic echography and scintigraphy in patients with beta-thalassemia given multiple transfusions].
    Agnello D; Bruno R; Malizia R; Volpe FP; Lo Iacono F
    Minerva Pediatr; 1985 Sep; 37(17):587-92. PubMed ID: 3908892
    [No Abstract]   [Full Text] [Related]  

  • 40. [Splenectomy in Cooley's disease. Our experience and long-term results].
    Forteleoni G; Mulas G; Careddu F; Lendini M; Pacitti C; Antona C
    Minerva Chir; 1984 Sep; 39(18):1237-43. PubMed ID: 6504365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.